Editas Medicine Inc. (EDIT)
1.77
-0.15 (-7.81%)
At close: Mar 03, 2025, 3:59 PM
1.83
3.38%
After-hours: Mar 03, 2025, 04:22 PM EST
Editas Medicine Balance Sheet Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Cash & Equivalents | 123.65M | 141.52M | 203.52M | 139.68M | 238.18M | 134.78M | 146.63M | 185.32M | 143.18M | 10.62M | 2.01M |
Short-Term Investments | 199.46M | 202.75M | 296.33M | 262.43M | 218.96M | 234.18M | 182.51M | n/a | n/a | n/a | n/a |
Long-Term Investments | 104.02M | 93.1M | 120.07M | 109.66M | 5.29M | 5.38M | 1.62M | 1.62M | n/a | n/a | n/a |
Other Long-Term Assets | 8.59M | 5.25M | 6.81M | 4.7M | 107K | n/a | n/a | n/a | 2.25M | 360K | 340K |
Receivables | 10.19M | 5.14M | 267K | 6.05M | 418K | 30K | 679K | 88K | 1.02M | n/a | n/a |
Inventory | n/a | -93.1M | -120.07M | -109.66M | n/a | 2.92M | 1.86M | 1.66M | 780K | n/a | n/a |
Other Current Assets | 7.53M | 7.33M | 14.4M | 21.86M | 12.57M | 5.79M | 2.38M | 1.77M | 786K | 93K | 77K |
Total Current Assets | 340.83M | 356.75M | 507.31M | 419.09M | 463.84M | 374.78M | 332.2M | 187.18M | 144.99M | 10.72M | 2.09M |
Property-Plant & Equipment | 45.71M | 59.22M | 43.29M | 39.15M | 39.65M | 40.23M | 39.44M | 40.38M | 2.13M | 1.11M | 52K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 158.32M | 157.57M | 170.17M | 153.51M | 45.04M | 45.61M | 41.06M | 42M | 4.38M | 1.47M | 392K |
Total Assets | 499.15M | 514.32M | 677.48M | 572.6M | 508.88M | 420.39M | 373.26M | 229.18M | 149.36M | 12.19M | 2.48M |
Account Payables | 8.27M | 9.51M | 5.05M | 6.41M | 5.84M | 5.33M | 4.02M | 4.64M | 1.38M | 2.6M | 404K |
Deferred Revenue | 8.22M | 8.22M | 11.33M | 20.94M | 23.51M | 15.71M | 13.24M | 26M | 88K | 1.69M | n/a |
Short-Term Debt | 24.17M | 22.16M | 20.62M | 13.62M | 11.61M | n/a | 7.5M | 10M | n/a | 67K | n/a |
Other Current Liabilities | 34.56M | 20.21M | 9.88M | 17.23M | 19M | 14.86M | 11.95M | 18.44M | 5.46M | 3.5M | 1.72M |
Total Current Liabilities | 63.22M | 60.11M | 46.88M | 58.21M | 59.96M | 35.9M | 36.71M | 33.08M | 6.92M | 6.16M | 2.13M |
Long-Term Debt | 24.37M | 32.86M | 16.07M | 19.32M | 23.28M | 32.42M | 33.43M | 35.1M | 199.91M | 344K | 2.11M |
Other Long-Term Liabilities | 1.8M | n/a | n/a | 27.5M | 1K | 293K | 317K | 396K | 316K | 20.98M | 5K |
Total Long-Term Liabilities | 86.84M | 93.53M | 76.96M | 120.81M | 186.49M | 148.32M | 128.47M | 61.49M | 225.55M | 21.32M | 2.12M |
Total Liabilities | 150.06M | 153.64M | 123.84M | 179.02M | 246.45M | 184.22M | 165.18M | 94.58M | 232.48M | 27.48M | 4.24M |
Total Debt | 36.54M | 43.95M | 26.38M | 26.14M | 29.08M | 32.42M | 33.43M | 35.1M | 199.91M | 411K | 2.11M |
Common Stock | 8K | 7K | 7K | 6K | 5K | 5K | 4K | 4K | n/a | n/a | n/a |
Retained Earnings | -1.23B | -1.08B | -857.7M | -665.2M | -549.22M | -416.28M | -305.85M | -185.53M | -88.35M | -15.45M | -1.76M |
Comprehensive Income | 198K | -3.6M | -493K | -46K | 107K | -29K | -76K | -229.18M | n/a | n/a | n/a |
Shareholders Equity | 349.1M | 360.68M | 553.64M | 393.59M | 262.44M | 236.16M | 208.08M | 134.61M | -83.11M | -15.29M | -1.76M |
Total Investments | 303.48M | 295.85M | 416.4M | 372.09M | 218.96M | 234.18M | 182.51M | 1.62M | n/a | n/a | n/a |